Literature DB >> 22565120

Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal.

Karim Si-Tayeb1, Jean-Charles Duclos-Vallée, Marie-Anne Petit.   

Abstract

Entities:  

Year:  2012        PMID: 22565120     DOI: 10.1016/j.jhep.2012.04.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

Review 1.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

Review 2.  Malaria modeling: In vitro stem cells vs in vivo models.

Authors:  Florian Noulin
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

Review 3.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

4.  Guidelines for the use of cell lines in biomedical research.

Authors:  R J Geraghty; A Capes-Davis; J M Davis; J Downward; R I Freshney; I Knezevic; R Lovell-Badge; J R W Masters; J Meredith; G N Stacey; P Thraves; M Vias
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

5.  In vitro systems for the study of hepatitis C virus infection.

Authors:  Garrick K Wilson; Zania Stamataki
Journal:  Int J Hepatol       Date:  2012-09-27

6.  Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.

Authors:  Khanit Sa-Ngiamsuntorn; Suradej Hongeng; Adisak Wongkajornsilp
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-08-14

Review 7.  Clinical therapy using iPSCs: hopes and challenges.

Authors:  Xiao Lu; Tongbiao Zhao
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-09-21       Impact factor: 7.691

8.  A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.

Authors:  Khanit Sa-Ngiamsuntorn; Adisak Wongkajornsilp; Phetcharat Phanthong; Suparerk Borwornpinyo; Narisorn Kitiyanant; Wasun Chantratita; Suradej Hongeng
Journal:  Virol J       Date:  2016-04-05       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.